Mergers and Acquisitions

SAP posted 2017 results on the lower side of market expectations and announced a $2.4 billion U.S. acquisition.

The owner of the Charleston Gazette-Mail, which won a Pulitzer Prize last year for its coverage of the state's opioid drug crisis, has warned its entire staff of pending layoffs and said it plans to file for Chapter 11 bankruptcy and find a potential buyer.

Keurig is buying Dr. Pepper Snapple Group Inc., creating a beverage giant with about $11 billion in annual sales.

Buyer seeks to build food-and-beverage empire that can compete with Coca-Cola and Pepsi.

Shareholders of Avon Products Inc, led by activist investor Shah Capital on Monday called on the cosmetics maker to explore strategic options, including a sale.

Keurig Green Mountain will buy soda maker Dr Pepper Snapple Group Inc in a deal worth more than $21 billion,

U.S. packaging company WestRock Co said on Monday it would buy KapStone Paper and Packaging Corp for an enterprise value of about $4.9 billion

French drugmaker Sanofi has agreed to buy Belgian biotech company Ablynx for $4.8 billion, beating Novo Nordisk and marking its second big deal this month after buying Bioverativ.

"Some of the things he is doing, with all due respect, work," John Paul DeJoria tells FOX Business.

Facebook is buying Boston-based software company Confirm Inc, which specializes in authenticating government-issued identification cards, a person familiar with the acquisition told Reuters.

Bacardi has agreed to buy out Patron Spirits International in a deal valuing the top high-end tequila maker at $5.1 billion, highlighting the appetite big drinks groups have for the Mexican spirit.

The U.K.'s antitrust regulator has provisionally found the proposed acquisition of British pay-TV giant Sky by 21st Century Fox isn't in the public interest due to plurality concerns.

Puerto Rico's governor says he is privatizing the island's government-owned power company following decades of mismanagement, corruption and blackouts.

Celgene Corp said on Monday it would pay about $9 billion in cash to acquire the rest of Juno Therapeutics Inc and gain access to Juno's experimental gene therapy to treat cancer.

American International Group on Monday said it would buy property and casualty reinsurer Validus Holdings for $5.56 billion in cash to strengthen its general insurance business.

French healthcare group Sanofi has agreed to buy U.S. peer Bioverativ for $11.6 billion.

Investor Carl Icahn and Darwin Deason, major shareholders of Xerox, jointly plan to push the printer and photocopier maker to explore options, including a sale of the firm.